loading

Sangamo Therapeutics Inc (SGMO) 財務データ

損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
期間の長さ 3 か月 3 か月 3 か月 3 か月 3 か月
Revenues
184.39%
18.31
6.437 7.551 49.41 0.356
Operating Expenses
0.27%
36.16
36.06 33.54 38.78 37.44
Benefits Costs and Expenses
3.66%
38.27
36.91 31.37 38.65 36.41
Costs And Expenses
3.66%
38.27
36.91 31.37 38.65 36.41
Operating Income/Loss
39.74%
-17.86
-29.63 -25.99 10.63 -37.08
Income/Loss From Continuing Operations Before Tax
34.51%
-19.96
-30.48 -23.82 10.76 -36.05
Income Tax Expense/Benefit
77.31%
0.027
0.119 -0.427 0.088 0.074
Income/Loss From Continuing Operations After Tax
34.68%
-19.99
-30.60 -23.40 10.67 -36.13
Net Income/Loss
34.68%
-19.99
-30.60 -23.40 10.67 -36.13
Preferred Stock Dividends And Other Adjustments
-
- - 1.287 -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
16.65%
256.95
220.27 2.85 208.34 203.95
Diluted Average Shares
16.65%
256.95
220.27 2.85 214.32 203.95
Basic Earnings Per Share
42.86%
-0.08
-0.14 -0.12 0.05 -0.18
Diluted Earnings Per Share
42.86%
-0.08
-0.14 -0.12 0.04 -0.18
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - 2.574 -
$84.54
price up icon 0.86%
$22.91
price up icon 7.03%
$32.47
price up icon 2.06%
$102.71
price up icon 0.62%
$166.10
price up icon 2.22%
biotechnology ONC
$331.09
price up icon 3.45%
大文字化:     |  ボリューム (24 時間):